This compound is a pharmaceutical intermediate used as an impurity reference standard for amikacin. It is structurally related to the aminoglycoside antibiotic amikacin and serves as a quality control standard in pharmaceutical manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1793053-92-5
(2S)-4-amino-N-[(1R,4R,5R)-5-amino-4-[(2R,4R,5S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-2-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
pharmaceutical raw material
1,3-Di-HABA Kanamycin A
aminoglycoside antibiotic intermediate
1,6'-Di-HABA Kanamycin A
amikacin impurity reference standard
Tert-butyl N-(4-oxocyclohexyl)carbamate
pharmaceutical intermediate
(R)-BoroLeu-(+)-Pinanediol trifluoroacetate
impurity or intermediate for bortezomib synthesis
1-(4,5-Dihydrothiazol-2-yl)azetidine-3-thiol hydrochloride
Pharmaceutical intermediate for Tebipenem
(2R,4S)-tert-butyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate
Pharmaceutical intermediate
Amikacin Impurity 11
Amikacin impurity reference standard
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxycyclohexyl]-2-hydroxybutanamide
HMOKJJPLZODRRD-BCUZZYETSA-N
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O)N